Michel Vounatsos - 10 Feb 2022 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Chief Executive Officer, Director
Signature
/s/ Wendell Taylor, attorney-in-fact for Michel Vounatsos
Issuer symbol
BIIB
Transactions as of
10 Feb 2022
Transactions value $
$0
Form type
4
Filing time
14 Feb 2022, 15:15:46 UTC
Previous filing
21 Jan 2022
Next filing
15 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIIB Common Stock 63.7K 10 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Award $0 +28.4K $0.00 28.4K 10 Feb 2022 Common Stock 28.4K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.